Answers are grounded in this paper and cite their sources.
Terbium-161 is a promising radionuclide for targeted radionuclide therapy because its decay characteristics combine therapeutic beta particles and short-range conversion and Auger electrons with gamma emissions suitable for imaging and dosimetry. Reactor production via the 160 Gd(n,γ) 161 Gd→ 161 Tb pathway requires efficient separation of trace terbium from the bulk gadolinium target matrix. This study investigated the temperature dependence of terbium–gadolinium separation by cation-exchange chromatography using Dowex 50W-X8 resin and α-hydroxyisobutyric acid (α-HIBA) as a complexing eluent. Neutron-activated gadolinium and a radioactive terbium tracer were processed at column temperatures of 30, 50, and 70°C. The terbium tracer served as a chemical and radiometric surrogate for the terbium fraction associated with 161 Tb; the direct yield of 161 Tb production was not determined. The eluent concentration was 0.3 M α-HIBA at pH 4.40. Fractions were collected at 5 mL intervals and analyzed by high-purity germanium gamma spectrometry. Terbium eluted before gadolinium at all temperatures investigated. Nominal terbium recovery increased from 97% at 30°C to 98% at 50°C and 99% at 70°C, whereas nominal gadolinium contamination decreased from 2.0% to 0.1%. The best separation was obtained at 70°C. Each temperature condition was tested once, so the results are descriptive rather than statistically replicated. Detector calibration uncertainty, background-spectrum uncertainty, and complete efficiency-calibration records were not available for reconstruction; consequently, the reported recovery and contamination values should be treated as nominal single-run values pending verification against the original laboratory records.
No takes yet. Share an insight, caveat, or question.
Bello et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: